5-6 m

( Treitz
)
: 2/3
: 1/3


A (
)
(

Peyer)
(
,
)




(
200-500 m2)



Paneth ( ;)
(,
, ,
, )
M (
)


( )

  ( ,
, )
 ( )


V 

(, ,
, )
:
: , VIP

 

( )

, , ,
, ( Ca++ )

( )




(<3m )


(
, B12)


<1m

(, , )



  (
)
     (
)

  ! (
)

(
)
(
)


( )


( )


(, )

60%
10%
20%
10%

)
()
( )


( )


( )
" 
(,
12 ,
)





/


( )
# 


( )


:

(
)


( )

(
)

 Crohn

2 9 / 100.000
: 20-90 / 100.000
2 4 10



, , ,

HLA-B27 ( )

:
10-20
: 36%
. Crohn

 /

(, o paratuberculosis,
avium, Yersinia enterocolitica;)

(
)

: 75-90%
: 15-30%
: 40-60%
: 25-30%
: 0,5-7%

skip lesions: 15%

: 100%

,
( )
50-70%
25%

>>
 $$%&$#


# 


% #  & 

skip areas

   &#





,

, ( )
#


60% <40
10% <10
/

/

/
/ /

( )
90%
, , ,

, /

. Crohn
: 15%
o

30%

15%
:

/ /

10%




15-25%
50-75%

( )

    &%  

   % ! $ %
 


 
' 

&
 (
$ (   !

'

  
 $ 
!
%

 ! )
*+,-.)

( )

, ,
:

skip lesions

, ,

, , ,

111In




. Crohn

Mantoux

,
/ / Yersinia

/ /

NSAIDs



(1-2%)

90% ( )
10%
Hartmann
+
)
, ,

( )

, , ,

(<500 ml )
(>500 ml )
)


(20%)

, ,
, C/T scan

:
:

35%
. Crohn

(%/

  0

. Crohn

   % %

20-30
. Crohn
HLA-B27
. Crohn
. Crohn


%
#  &


,


( / )

# &(

( #  &
/
%%$

%%0
   
%

10%

15-35%

( )

5-10%

30%

10%

0,25-0,75mg


5- (5-ASA)






(
, , , ,
, , )


/

+


(>4-6 )

60%

infliximab (anti-TNF )
()


6-7%

75% . Crohn
:

( )
: ~ 3

(3.1 /)

3#

resolve complication preserve bowel


(stricturoplasty)



Hartmann


-
#  #


30% ( )
1# #


   25% ()
1# #


 
 ( ,
, , )

  &
 3
3 #    6

2 
   (
, )

, ,




(50%)
CPK ( )
,



/
( , )


:
C/T : 25-50%
:

(triplex):
( )

12






(
)
, , ,



(apudomata)

MEN1 2
( :10-15%)
2

3


/

0

 
% 

:
, ,

(, , )
5 : 70%




3
60

, , ,







( , , rebound)
(, )
,
( )
( )




/ (
)
:
plastron
C/T scan :

12





Crohn

:
(
,
, )
,
:
(,
)

> 2cm
:25%

(3%)

3
&# 
# : >2cm,

,

50%





:

(,
)
,
: